ASHM Report Back

Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.

Cobistat

Posted by on in New ARV Treatment, clinical trials emerging therapy
  • Font size: Larger Smaller
  • Hits: 11973
  • Print

The new "booster" drug, COBISTAT, is part of the "QUAD" single pill (see QUAD post) and a number of studies are in planning and in progress looking at the use of this agent. It may allow new regimens such as a once daily combination pill with a protease inhibitor for the first time.

Tagged in: CROI2012
  • No comments made yet. Be the first to submit a comment

Leave your comment

Guest
Guest Saturday, 16 January 2021

RT @DrJasonJOng: Please check out our new publication led by @EricPFChow on HIV testing and diagnoses during the COVID-19 pandemic in Melbo…

ASHM ASHM

RT @napwha: #Jobs: NAPWHA is looking for a Campaigns Project Officer to join our team working from Syd to deliver exciting projects in 2021…

ASHM ASHM

Stay STI Free is a new initiative by the Victorian Sexual Health Network. You can view their comprehensive website… https://t.co/L9rwn0lqGo

ASHM ASHM